NCT05802654View on ClinicalTrials.gov

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2028

Conditions
Early Lung CancerStereotactic Body Radiotherapy
Interventions
RADIATION

SBRT

The participants enrolled will receive single fraction of ultra-high dose SBRT(30Gy/1F).

Trial Locations (1)

100191

Department of radiation oncology, Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT05802654 - Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer | Biotech Hunter | Biotech Hunter